의료기기관련기관/국가임상시험지원재단54 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 12.27. (금) 구분보고서(영문)제약/바이오/임상시험(11건)Cell and Gene Therapy Companies Must Demonstrate Strong Value Proposition for InvestmentRSV Prophylactic Market to Reach $6.2 Billion in 8MM by 2030Schizophrenia Market Expected to Reach $17.0 Billion Across the 7MM by 2031DREAM-HF Trial Sheds Positive Light on Revascor for Ischemic HFPositive Interim Phase IIb Data Shows Promise of First Blood-Stage Malaria VaccineBiote.. 2025. 1. 6. 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 12.06. (금) 구분보고서(영문)제약/바이오/임상시험(8건)Europe’s TCR Immunotherapy Licensing Deals Surge 123% Higher than US in 2024Exploring Drug Shortages in European Markets: the Causes, Analysis, and ResponseFailure of AstraZeneca’s AZD4041 a Blow for Non-Opioid Treatments for Opioid Use DisorderFDA Approves Medtronic InPen App, Launching Smart MDI System with Simplera CGMBio/Pharmaceutical Outsourcing Report, November 202.. 2025. 1. 6. 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 11.22. (금) 구분보고서(영문)제약/바이오/임상시험(3건)Positive Phase II Top-Line Data Highlights Omadacycline’s Potential in the NTM MarketContract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share, and Outlook – 2024 EditionStrategic Intelligence: AI in Drug Discovery 2024컨퍼런스/심포지엄/학회/기타(11건)IDWeek 2024: Strategic Approaches and Challenges in Mpox VaccinationAHA 2024: Plozasiran Demonstrates Promis.. 2025. 1. 6. 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 11.08. (금) 구분보고서(영문)제약/바이오/임상시험(8건)Second Alzheimer’s Drug Rejected by NICE on the Same Day It Is Approved in the UKEU Critical Medicines Act: Proposal Is One Step Closer to Ending Overreliance on Asian ManufacturersRoche to Leverage Dyno Therapeutics Tech for Novel Gene Therapies in Neurological DisordersStrategic Intelligence: Big Data in Pharma 2024Strategic Intelligence: Digital Transformation and Emer.. 2025. 1. 6. 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 10.25. (금) 구분보고서(영문)제약/바이오/임상시험(6건)Venture Capital Investment Trends In Pharma - Q3 2024M&A Trends in Pharma - Q3 2024Results of Phase I Trial Shed Positive Light on UNI-494 for Acute Kidney InjuryQ3 2024 CRO Activity and Intel ReportUnresolved Clawback Issues Obstruct Greece’s Potential Pharmaceutical Framework AgreementOral GLP-1 Receptor Agonist Rybelsus Reduces Risk of Cardiovascular Events in Type 2 D.. 2025. 1. 6. 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 10.11. (금) 구분보고서(영문)제약/바이오/임상시험(8건)US’s First Self-Administered Flu Vaccine Could Increase Accessibility and UptakeSanofi/Regeneron’s Dupixent Set to Dominate COPD Biologics Market Following FDA ApprovalEmerging Market Outsourcing Report – Q3 2024Asia-Pacific Dominates For Endometriosis TrialsKeytruda and Opdivo: A Decade ReviewCrucial Drug Shortages Initiate Call for Action to Include Pregnant Women in Cl.. 2025. 1. 6. 이전 1 2 3 4 ··· 9 다음